EsoBiotec
- 0756.885.159
- BE0756885159
- Rue André Dumont 5, 1435 Mont-Saint-Guibert
- See the 3 companies at this address
- 22 October 2020
Profile
Official information from the CBE (FPS Economy).
EsoBiotec is a Belgian company (Société anonyme) whose registered office is established at 1435 Mont-Saint-Guibert. Its main activity falls under “Recherche-développement en autres sciences physiques et naturelles” (NACE 72109).
- Legal form
- Société anonyme
- Legal situation
- Situation normale
- Date of incorporation
- 22 October 2020
- Main activity (NACE)
- 72109Recherche-développement en autres sciences physiques et naturelles
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Secondary activities
1 additional NACE code declared.
Your risk analysis on this company
AML Company ran EsoBiotec through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Multi-year summary extracted from the annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | €12,414,984 | €7,732,667 | €26,772,082gross margin | 9,4 |
| 2022 | €5,051,745 | -€1,002,978 | €2,176,305gross margin | – |
| 2021 | €2,303,912 | -€198,317 | €82,332gross margin | – |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
This year's filing does not carry the item the calculation needs.
Result for the year / turnover
This year's filing does not carry the item the calculation needs.
Operating result / turnover
This year's filing does not carry the item the calculation needs.
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2022 | 2021 | Trend |
|---|---|---|---|---|
| Solvency | 75,3% 6% | 69,3% 20,7% | 48,6% | |
| Liquidity | 4,07 x 5,93 | 10 x 0,74 | 9,26 x | |
| Net margin | - | - | - | - |
| Operating margin | - | - | - | - |
| Long-term debt | - | 8,4% | - | - |
| Return on equity | 62,3% 82,1% | -19,9% 11,2% | -8,6% |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (3)▾
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- DEMISSIONS, NOMINATIONS15 July 2026
- DEMISSIONS, NOMINATIONS27 October 2025
- DEMISSIONS, NOMINATIONS25 July 2025
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
Frequently asked questions about EsoBiotec
Quick answers on EsoBiotec's identity, contact details and official CBE information.
What is EsoBiotec's enterprise number (CBE)?
What is EsoBiotec's VAT number?
Where is EsoBiotec's registered office?
What is EsoBiotec's legal form?
When was EsoBiotec incorporated?
Is EsoBiotec still active?
What is EsoBiotec's main activity?
How many establishments does EsoBiotec have?
Has EsoBiotec filed its annual accounts?
Which official notices concern EsoBiotec?
Is EsoBiotec subject to anti-money-laundering obligations in Belgium?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 7 July 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m01-fFiled accounts2026-00275331
- 2025
- 2024
- 29 August 2024Articles of association · Capital · Shares · Appointments · ResignationsView the notice24424741
- 2023
- 29 June 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m07-fFiled accounts2023-00173621
- 2022
- 5 July 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m07-fFiled accounts2022-20151103
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
IMMUNOVACC CONSULTING
Tools4Patient
NOVADIP BIOSCIENCES
Ncardia Holding
The Akkermansia Company
Celyad Oncology
OYSTERSHELL
Endymion
Inokura
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.